Dr. Lisa Connery
Claim this profileAlliance for Multispecialty Research, LLC
Expert in Type 2 Diabetes
Expert in Diabetes
22 reported clinical trials
18 drugs studied
About Lisa Connery
Education:
- Bachelor of Science in Psychology, University of Oklahoma.
- Doctor of Medicine (MD), University of Oklahoma College of Medicine.
- Completed Residency in Family Practice, University of Oklahoma.
Experience:
- Has been practicing family medicine since 1991.
- Owned and operated her own family practice since 2005.
- Serves as Medical Director for the Department of Health in Cleveland and McClain Counties since 2014.
- Founded Intend Research in 2016, which became AMR Norman, and has been the Principal Investigator there since 2016, conducting over 80 clinical research studies with a focus on diabetes.
Affiliated Hospitals
Clinical Trials Lisa Connery is currently running
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
Orforglipron vs Semaglutide
for Type 2 Diabetes
The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.
Recruiting2 awards Phase 33 criteria
More about Lisa Connery
Clinical Trial Related1 year of experience running clinical trials · Led 22 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Lisa Connery has experience with
- Placebo
- Tirzepatide
- Dulaglutide
- Insulin Efsitora Alfa
- Orforglipron
- Insulin Glargine
Breakdown of trials Lisa Connery has run
Type 2 Diabetes
Diabetes
Obesity
Colorectal Cancer
- Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
- Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Connery specialize in?
Lisa Connery focuses on Type 2 Diabetes and Diabetes. In particular, much of their work with Type 2 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Lisa Connery currently recruiting for clinical trials?
Yes, Lisa Connery is currently recruiting for 6 clinical trials in Norman Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Lisa Connery has studied deeply?
Yes, Lisa Connery has studied treatments such as Placebo, Tirzepatide, Dulaglutide.
What is the best way to schedule an appointment with Lisa Connery?
Apply for one of the trials that Lisa Connery is conducting.
What is the office address of Lisa Connery?
The office of Lisa Connery is located at: Alliance for Multispecialty Research, LLC, Norman, Oklahoma 73069 United States. This is the address for their practice at the Alliance for Multispecialty Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.